Viewing Study NCT00621218


Ignite Creation Date: 2025-12-25 @ 4:53 AM
Ignite Modification Date: 2026-03-03 @ 2:20 AM
Study NCT ID: NCT00621218
Status: COMPLETED
Last Update Posted: 2008-12-18
First Post: 2008-02-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea
Sponsor: Coria Laboratories, Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module